This funding opportunity supports clinical trials of products aimed at evaluating efficacy and safety to support new indications or labeling changes addressing unmet needs in rare diseases. It encourages collaborative and innovative trial designs to increase approved treatments and positively impact rare disease drug development.
Eligibility details are not fully specified; applicants should refer to the "Additional Information on Eligibility" section for clarification. The opportunity is likely open to entities involved in clinical trials for rare diseases.
